G-rich polynucleotides for the treatment of Huntington's Disease

Details for Australian Patent Application No. 2006302022 (hide)

Owner University of Delaware

Inventors Parekh-Olmedo, Hetal; Kmiec, Eric B.

Agent Shelston IP

Pub. Number AU-A-2006302022

PCT Pub. Number WO2007/044851

Priority 60/724,085 06.10.05 US

Filing date 6 October 2006

Wipo publication date 19 April 2007

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/044851 Priority application(s): WO2007/044851

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006302023-Battery with bifunctional electrolyte

2006302017-Systems and methods for detecting fluids